Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Leamon

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
Molecular Pharmacology|September 17, 2004
Ligand binding and kinetics of folate receptor recycling in vivo: impact on receptor-mediated drug deliveryChrystal M Paulos, Joseph A Reddy, Christopher P Leamon, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 16, 2008
Impact of high and low folate diets on tissue folate receptor levels and antitumor responses toward folate-drug conjugatesChristopher P Leamon, Joseph A Reddy, Ryan Dorton, et al.
Bioconjugate Chemistry|September 21, 2006
Synthesis and biological evaluation of EC140: a novel folate-targeted vinca alkaloid conjugateChristopher P Leamon, Joseph A Reddy, Iontcho R Vlahov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2014
Rational combination therapy of vintafolide (EC145) with commonly used chemotherapeutic drugsJoseph A Reddy, Ryan Dorton, Alicia Bloomfield, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 9, 2016
Development and validation of a UPLC-MS/MS method for the novel folate-targeted small molecule drug conjugate EC1456 and its metabolites in tumor homogenates from miceSatish I Rao, Michael Pugh, Melissa Nelson, et al.
Cancer Chemotherapy and Pharmacology|December 7, 2005
Folate receptor specific anti-tumor activity of folate-mitomycin conjugatesJoseph A Reddy, Elaine Westrick, Iontcho Vlahov, et al.
Analytical Biochemistry|March 5, 2005
Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assayNikki Parker, Mary Jo Turk, Elaine Westrick, et al.
Molecular Pharmaceutics|September 6, 2007
Folate-targeted dinitrophenyl hapten immunotherapy: effect of linker chemistry on antitumor activity and allergic potentialYingjuan Lu, Fei You, Iontcho Vlahov, et al.
Drug Discovery Today|July 30, 2009
The changing landscape of cancer drug discovery: a challenge to the medicinal chemist of tomorrowKlaus Pors, Frederick W Goldberg, Christopher P Leamon, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2011
Acid mediated formation of an N-acyliminium ion from tubulysins: a new methodology for the synthesis of natural tubulysins and their analogsIontcho R Vlahov, Yu Wang, Marilynn Vetzel, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Molecular Pharmacology|September 17, 2004
Ligand binding and kinetics of folate receptor recycling in vivo: impact on receptor-mediated drug deliveryChrystal M Paulos, Joseph A Reddy, Christopher P Leamon, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 16, 2008
Impact of high and low folate diets on tissue folate receptor levels and antitumor responses toward folate-drug conjugatesChristopher P Leamon, Joseph A Reddy, Ryan Dorton, et al.
Bioconjugate Chemistry|September 21, 2006
Synthesis and biological evaluation of EC140: a novel folate-targeted vinca alkaloid conjugateChristopher P Leamon, Joseph A Reddy, Iontcho R Vlahov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2014
Rational combination therapy of vintafolide (EC145) with commonly used chemotherapeutic drugsJoseph A Reddy, Ryan Dorton, Alicia Bloomfield, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 9, 2016
Development and validation of a UPLC-MS/MS method for the novel folate-targeted small molecule drug conjugate EC1456 and its metabolites in tumor homogenates from miceSatish I Rao, Michael Pugh, Melissa Nelson, et al.
Cancer Chemotherapy and Pharmacology|December 7, 2005
Folate receptor specific anti-tumor activity of folate-mitomycin conjugatesJoseph A Reddy, Elaine Westrick, Iontcho Vlahov, et al.
Analytical Biochemistry|March 5, 2005
Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assayNikki Parker, Mary Jo Turk, Elaine Westrick, et al.
Molecular Pharmaceutics|September 6, 2007
Folate-targeted dinitrophenyl hapten immunotherapy: effect of linker chemistry on antitumor activity and allergic potentialYingjuan Lu, Fei You, Iontcho Vlahov, et al.
Drug Discovery Today|July 30, 2009
The changing landscape of cancer drug discovery: a challenge to the medicinal chemist of tomorrowKlaus Pors, Frederick W Goldberg, Christopher P Leamon, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2011
Acid mediated formation of an N-acyliminium ion from tubulysins: a new methodology for the synthesis of natural tubulysins and their analogsIontcho R Vlahov, Yu Wang, Marilynn Vetzel, et al.
Pageof 8